Come up with a name for your new list and we'll add to it:
TearSolutions raised a round of funding on January 01, 2017. Investors include
University of Virginia.
TearSolutions is a drug development company focusing on 'dry eye', the most common eye disease. TearSolutions aims to advance a novel tear generation therapy for dry eye through phase II human clinica…